Drug Interactions between Afrin NoDrip Severe Congestion and levothyroxine
This report displays the potential drug interactions for the following 2 drugs:
- Afrin NoDrip Severe Congestion (oxymetazoline nasal)
- levothyroxine
Interactions between your drugs
No interactions were found between Afrin NoDrip Severe Congestion and levothyroxine. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
Afrin NoDrip Severe Congestion
A total of 47 drugs are known to interact with Afrin NoDrip Severe Congestion.
- Afrin nodrip severe congestion is in the drug class nasal antihistamines and decongestants.
- Afrin nodrip severe congestion is used to treat Nasal Congestion.
levothyroxine
A total of 199 drugs are known to interact with levothyroxine.
- Levothyroxine is in the drug class thyroid drugs.
- Levothyroxine is used to treat the following conditions:
Drug and food interactions
levothyroxine food
Applies to: levothyroxine
The timing of meals relative to your levothyroxine dose can affect absorption of the medication. Therefore, levothyroxine should be taken on a consistent schedule with regard to time of day and relation to meals to avoid large fluctuations in blood levels, which may alter its effects. In addition, absorption of levothyroxine may be decreased by foods such as soybean flour, cotton seed meal, walnuts, dietary fiber, calcium, and calcium fortified juices. These foods should be avoided within several hours of dosing if possible. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
When levothyroxine is given during continuous enteral nutrition (tube feedings) for more than 7 days, the tube feeding should be interrupted for at least one hour before and one hour after the dose of levothyroxine. You may need more frequent blood tests to monitor levothyroxine levels.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See Also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.